跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
COUGH-EN LINCTUS - HSA Drug Approval Details
Approvals
/
HSA
/
COUGH-EN LINCTUS
Approved
THERAPEUTIC
COUGH-EN LINCTUS
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
Jul 3, 1996
Approval ID
44dc12fbc6ff03c3
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
44dc12fbc6ff03c3
Drug Name
COUGH-EN LINCTUS
Product Name
COUGH-EN LINCTUS
Approval Number
SIN08780P
Approval Date
1996-07-03
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PHARMACY ONLY MEDICINES
Dosage Form
ELIXIR
Route Of Administration
ORAL
Atc Code
R05DA20
Atc Item Name
combinations
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Company Detail Path
/organization/apex-pharma-marketing-pte-ltd
Active Ingredients
DEXTROMETHORPHAN HBr
15 mg/5 ml
TRIPROLIDINE HCl
1.25 mg/5 ml
PSEUDOEPHEDRINE HCl
30 mg/5 ml
DEXTROMETHORPHAN HBR
15 MG/5 ML
PSEUDOEPHEDRINE HCL
30 MG/5 ML
TRIPROLIDINE HCL
1.25 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 3, 1996
Approval ID
44dc12fbc6ff03c3
Type
Therapeutic
Back to HSA Approvals